Search results for "Cardiovascular Disease"


 
Results 81 - 90 of about 408 for "Cardiovascular Disease".
Sort by: Relevance | Newest | Oldest

ACC updates decision pathway on nonstatin drugs in ASCVD

Experts considered evidence from the FOURIER trial and the SPIRE-1 and SPIRE-2 trials, as well as evidence on addition of ezetimibe to statin therapy after acute coronary syndrome.
https://immattersacp.org/weekly/archives/2017/09/12/1.htm
12 Sep 2017

Guidance issued on drug-drug interactions for statins, heart meds

A new statement from the American Heart Association recommends that in patients taking amlodipine combined with simvastatin or lovastatin, the dosage of either statin should not exceed 20 mg/d, and for patients in whom statin-fibrate therapy is indicated, fenofibrate or fenofibric acid is preferred because of a lower rate of drug-drug interactions.
https://immattersacp.org/weekly/archives/2016/10/25/2.htm
25 Oct 2016

Calculating risk for cholesterol drugs

Differing guidelines and a new class of drugs may cause uncertainty on the part of patients and practitioners.
https://immattersacp.org/archives/2015/11/cholesterol.htm
1 Nov 2015

ADA issues updated position statement on hypertension and diabetes

The statement updates the ADA's 2003 position statement on this topic and summarizes clinical trials of intensive hypertension treatment strategies.
https://immattersacp.org/weekly/archives/2017/08/29/1.htm
29 Aug 2017

New options no panacea for depression

Internists can have the greatest impact by continuing to be the first point of contact, treating mild to moderate depression, and explaining what may be available if first-line options fall short.
https://immattersacp.org/archives/2019/09/new-options-no-panacea-for-depression.htm
1 Sep 2019

Setting goals to improve quality under MIPS

Five principles frequently define successful individual and organizational goal-setting and achievement. They can be applied as physicians convert to the Merit-Based Incentive Payment System, which will have a dramatic impact on future Medicare reimbursements.
https://immattersacp.org/archives/2017/03/policy.htm
1 Mar 2017

AHA releases scientific statement on acute MI in women

Differences in clinical presentation affect the timely identification, testing, and management of ischemic symptoms, leading to misdiagnosis, delayed revascularization, and higher acute myocardial infarction mortality rates.
https://immattersacp.org/weekly/archives/2016/02/02/2.htm
2 Feb 2016

Updated warnings on fluoroquinolones, new diabetes drug

This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016

Cardiovascular disease risk prediction models appear to work in black adults

A study reinforces the usefulness of ACC/AHA CVD Pooled Cohort risk equations and the importance of efforts to implement the current guidelines to prevent atherosclerotic cardiovascular disease in African Americans.
https://immattersacp.org/weekly/archives/2016/03/01/5.htm
1 Mar 2016

Minding your P's and M's

In medicine, internists need to mind not just their "P's and Q's" but their "P's and M's," that is, evidence-based practice and evidence-based medicine.
https://immattersacp.org/archives/2017/05/presidents.htm
1 May 2017

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next